PURSUE Trials

* There are no current open studies at PFC. Please check back again for any changes. *

We want you to know that all study protocols are evaluated for scientific merit by the Pacific Fertility Center Medical Board. Standards for study planning, informed consent, and safeguards are rigorously maintained. Research at PFC meets the standards developed by the federal Office for Human Research Protections (OHRP) branch of the Department of Human Health and Services. The OHRP has established criteria for oversight and review by an independent Investigational Review Board (IRB).

Currently, PFC has several ongoing research opportunities and others that are to be initiated at the first of the year. For further information feel free to browse our web site at www.pacificfertilitycenter.com/research.

One study open to enrollment at this time is utilizing an investigational new drug. The title of the study is “Effectiveness and Safety Research Study of a Single Injection of Investigational Drug compared to Daily recFSH Injections in Women Undergoing Controlled Ovarian Stimulation (PURSUE)”

Who Is Doing This Study?

Schering-Plough Research Institute has selected Pacific Fertility Center as one of about 35 study sites located in the United States to participate.

Why Are We Doing This Study?

The purpose of this study is to evaluate the effectiveness and safety of a single injection of corifollitropin alfa (an investigational drug) in inducing the development of multiple follicles, compared to daily injections of recFSH (300 IU [international units]). The number of fetuses (unborn babies) with heart activity (also referred to as a vital pregnancy) conceived in study subjects, along with the number of growing follicles, the number of eggs retrieved, the number of viable (good quality) embryos and the number of babies born will be determined as part of the objectives of this study.

Who is eligible?

Females who are:

• Suffering from infertility
• 35-42 years of age
• Weigh at least 110.3 lbs and have a Body Mass Index (BMI) of at least 18 but no more than 32
• Have regular spontaneous menstrual cycles every 24 to 35 days
• Will use their partner’s sperm derived from ejaculation or that of a sperm donor

This list is not all-inclusive. If you have questions regarding your eligibility to participate in this study, or would like to schedule an appointment for an evaluation, please contact us at 415-834-3095.

-Carolyn Givens, M.D. & Cynthia Willson, R.N., BSN

See all articles